High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination

MedPage Today) — A novel combination for relapsed/refractory multiple myeloma produced responses in about 80% of a heavily treated population, albeit with a high incidence of hematologic toxicity and infections.
The 94-patient cohort had an…